Accelerated Postero-Lateral Spinal Fusion by Collagen Scaffolds Modified with Engineered Collagen-Binding Human Bone Morphogenetic Protein-2 in Rats

Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive cytokine that plays a critical role in bone regeneration and repair. However, its distribution and side effects are major barriers to its success as therapeutic treatment. The improvement of therapy using collagen delivery matrices has been reported. To investigate a delivery system on postero-lateral spinal fusion, both engineered human BMP-2 with a collagen binding domain (CBD-BMP-2) and collagen scaffolds were developed and their combination was implanted into Sprague-Dawley (SD) rats to study Lumbar 4–5 (L4–L5) posterolateral spine fusion. We divided SD rats into three groups, the sham group (G1, n = 20), the collagen scaffold-treated group (G2, n = 20) and the BMP-2-loaded collagen scaffolds group (G3, n = 20). 16 weeks after surgery, the spines of the rats were evaluated by X-radiographs, high-resolution micro-computed tomography (micro-CT), manual palpation and hematoxylin and eosin (H&E) staining. The results showed that spine L4–L5 fusions occurred in G2(40%) and G3(100%) group, while results from the sham group were inconsistent. Moreover, G3 had better results than G2, including higher fusion efficiency (X score, G2 = 2.4±0.163, G3 = 3.0±0, p<0.05), higher bone mineral density (BMD, G2: 0.3337±0.0025g/cm3, G3: 0.4353±0.0234g/cm3. p<0.05) and more bone trabecular formation. The results demonstrated that with site-specific collagen binding domain, a dose of BMP-2 as low as 0.02mg CBD-BMP-2/cm3 collagen scaffold could enhance the posterolateral intertransverse process fusion in rats. It suggested that combination delivery could be an alternative in spine fusion with dramatically decreased side effects caused by high dose of BMP-2.

[1]  John R. Johnson,et al.  Posterolateral lumbar spine fusion with INFUSE bone graft. , 2007, The spine journal : official journal of the North American Spine Society.

[2]  J. Dettori,et al.  The use of rhBMP in spine surgery: is there a cancer risk? , 2012, Evidence-Based Spine-Care Journal.

[3]  F. Cui,et al.  Lumbar Spinal Fusion With a Mineralized Collagen Matrix and rhBMP-2 in a Rabbit Model , 2003, Spine.

[4]  Michael Chang,et al.  Transforaminal Lumbar Interbody Fusion With rhBMP-2 in Spinal Deformity, Spondylolisthesis, and Degenerative Disease—Part 2: BMP Dosage–Related Complications and Long-term Outcomes in 509 Patients , 2013, Spine.

[5]  Ralph Müller,et al.  Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. , 2013, Biomaterials.

[6]  John R. Johnson,et al.  The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. , 2008, The spine journal : official journal of the North American Spine Society.

[7]  R. Crystal,et al.  Combined Bone Morphogenetic Protein‐2 and −7 Gene Transfer Enhances Osteoblastic Differentiation and Spine Fusion in a Rodent Model , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  Bin Wang,et al.  Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. , 2007, Journal of biomedical materials research. Part A.

[9]  Zong-ping Luo,et al.  Collagen membrane alleviates peritendinous adhesion in the rat Achilles tendon injury model. , 2013, Chinese medical journal.

[10]  S. Boden,et al.  Spine update. The use of animal models to study spinal fusion. , 1994, Spine.

[11]  W. Friess,et al.  Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.

[12]  Jonathan N Grauer,et al.  Animal models for spinal fusion. , 2005, The spine journal : official journal of the North American Spine Society.

[13]  Raj D. Rao,et al.  Autograft containment in posterolateral spine fusion. , 2008, The spine journal : official journal of the North American Spine Society.

[14]  Jeffrey C. Wang,et al.  Challenges to bone formation in spinal fusion. , 2011, Journal of biomechanics.

[15]  Huilin Yang,et al.  The osteogenesis of bacterial cellulose scaffold loaded with bone morphogenetic protein-2. , 2012, Biomaterials.

[16]  Annette Kettler,et al.  Do early stages of lumbar intervertebral disc degeneration really cause instability? Evaluation of an in vitro database , 2010, European Spine Journal.

[17]  H. Yang,et al.  Improved spinal fusion efficacy by long-term delivery of bone morphogenetic protein-2 in a rabbit model , 2011, Acta orthopaedica.

[18]  Safdar N. Khan,et al.  Application of bone morphogenetic proteins in spinal fusion. , 2005, Cytokine & growth factor reviews.

[19]  J. Lane,et al.  Safety Profile for the Clinical Use of Bone Morphogenetic Proteins in the Spine , 2002, Spine.

[20]  Andrés J. García,et al.  Effects of protein dose and delivery system on BMP-mediated bone regeneration. , 2011, Biomaterials.

[21]  K. Jang,et al.  Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model. , 2011, Bone.

[22]  Jeffrey C. Wang,et al.  A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. , 2009, The spine journal : official journal of the North American Spine Society.

[23]  Bradley K Weiner,et al.  A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.

[24]  M. Spector,et al.  Comparing ectopic bone growth induced by rhBMP‐2 on an absorbable collagen sponge in rat and rabbit models , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  Bin Wang,et al.  Novel nerve guidance material prepared from bovine aponeurosis. , 2006, Journal of biomedical materials research. Part A.

[26]  Byung-Soo Kim,et al.  Controlled delivery of low-dose bone morphogenetic protein-2 using heparin-conjugated fibrin in the posterolateral lumbar fusion of rabbits. , 2013, Artificial organs.

[27]  H. Hsieh,et al.  Fabrication and release behavior of a novel freeze-gelled chitosan/gamma-PGA scaffold as a carrier for rhBMP-2. , 2006, Dental materials : official publication of the Academy of Dental Materials.

[28]  Jike Lu,et al.  Posterolateral Intertransverse Spinal Fusion Possible in Osteoporotic Rats With BMP-7 in a Higher Dose Delivered on a Composite Carrier , 2008, Spine.

[29]  D. Roffey,et al.  Osteoconductive Bone Graft Extenders in Posterolateral Thoracolumbar Spinal Fusion: A Systematic Review , 2012, Spine.

[30]  Mandi J. Lopez,et al.  Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[31]  S. Stock,et al.  Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. , 2013, Biomaterials.

[32]  Bin Wang,et al.  Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. , 2007, Biomaterials.

[33]  Daniel K. Park,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 With Local Bone Graft Instead of Iliac Crest Bone Graft in Posterolateral Lumbar Spine Arthrodesis , 2013, Spine.

[34]  G. Ling,et al.  Bone morphogenetic protein-2 used in spinal fusion with spinal cord injury penetrates intrathecally and elicits a functional signaling cascade. , 2010, The spine journal : official journal of the North American Spine Society.

[35]  E. Hurwitz,et al.  Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis. , 2013, The Journal of bone and joint surgery. American volume.

[36]  P. Buma,et al.  Evaluation of collagen/heparin coated TCP/HA granules for long-term delivery of BMP-2 , 2013, Journal of Materials Science: Materials in Medicine.

[37]  Michael J Yaszemski,et al.  Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. , 2008, Biomaterials.

[38]  J. M. Badura,et al.  Transient soft-tissue edema associated with implantation of increasing doses of rhBMP-2 on an absorbable collagen sponge in an ectopic rat model. , 2012, The Journal of bone and joint surgery. American volume.

[39]  A. Davis,et al.  Assessing mechanical integrity of spinal fusion by in situ endochondral osteoinduction in the murine model , 2010, Journal of orthopaedic surgery and research.